Working… Menu
Trial record 1 of 1 for:    PCR-MIB
Previous Study | Return to List | Next Study

Pembrolizumab With Chemoradiotherapy as Treatment for Muscle Invasive Bladder Cancer (PCR-MIB)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02662062
Recruitment Status : Recruiting
First Posted : January 25, 2016
Last Update Posted : January 20, 2021
Peter MacCallum Cancer Centre, Australia
Information provided by (Responsible Party):
Australian and New Zealand Urogenital and Prostate Cancer Trials Group

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 2023
Estimated Study Completion Date : January 2024